Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-08

Clinical Trial Update: Quality of Life In Patients With Allergic Conjunctivitis In Treatment With Sublingual Allergen Immunotherapy In A Referral Ophthalmological Hospital

View source ↗

Summary

This clinical trial update examines quality of life outcomes in patients with allergic conjunctivitis treated with sublingual allergen immunotherapy at a referr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sublingual allergen immunotherapy (sublingual allergen immunotherapy)

Snippet

Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana | Conditions: Allergic Conjunctivitis of Both Eyes | Status: ACTIVE_NOT_RECRUITING